Guangdong, China

Qingchun Ni

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Hainan Hualon Pharmaceutical Co., Ltd.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Qingchun Ni. Retrieved from https://idiyas.com/inventor/qingchun-ni

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Qingchun Ni

Introduction

Qingchun Ni is a notable inventor based in Guangdong, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of optically active compounds. His work focuses on innovative methods for treating infections, showcasing his dedication to advancing medical science.

Latest Patents

Qingchun Ni holds a patent for an optically active compound of prulifloxacin, which is used for treating infections. The patent details an anti-infection levorotatory optically active compound (S-configuration) of prulifloxacin, represented by a specific formula. The preparation method involves using levorotatory prulifloxacin as the raw material, with the reaction conducted in an organic solvent in the presence of alkaline materials. The reaction temperature ranges from -20°C to 60°C, and the reaction time varies from 15 minutes to 24 hours. This innovative approach highlights his expertise in pharmaceutical chemistry.

Career Highlights

Qingchun Ni is currently employed at Hainan Hualon Pharmaceutical Co., Ltd. His role at the company allows him to apply his knowledge and skills in a practical setting, contributing to the development of new pharmaceutical products. His work is instrumental in enhancing the effectiveness of treatments available for various infections.

Collaborations

Qingchun Ni collaborates with talented colleagues, including Jun Ying and Feng Peng. These partnerships foster a creative environment that encourages the exchange of ideas and expertise, further driving innovation in their projects.

Conclusion

Qingchun Ni's contributions to the field of pharmaceuticals, particularly through his patent on prulifloxacin, demonstrate his commitment to improving medical treatments. His work at Hainan Hualon Pharmaceutical Co., Ltd. and collaborations with colleagues underscore the importance of teamwork in driving innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…